1) Respiratory panel assays are medical tests used to detect various respiratory pathogens through molecular testing techniques like PCR, allowing for faster and more accurate diagnosis of respiratory infections. 2) Such assays are primarily used in hospitals and diagnostic laboratories to analyze infections in the respiratory tract and identify the pathogens causing diseases like influenza in order to quickly treat patients with the appropriate antibiotics or therapies. 3) The growing prevalence of respiratory diseases worldwide due to increasing pollution and urbanization is driving increased demand for respiratory panel assays as an effective way to curb infections through early detection and targeted treatment.

1. Global Market For Respiratory Panel Assays To Generate Substantial
Increment In Dollar Opportunities Through 2018 - 2026
Respiratory infections with the increasing pollution have become a major cause of infectious diseases
worldwide. These infectious diseases have become one of the causes of deaths in children and adults. With
the growing urbanization and industrialization, pollution has also increased at an alarming rate and has led
to an increase in bacterial and viral pathogens, which are the major the reasons of the respiratory infections.
Respiratory diagnosis has become important with the rise of infections, also new technologies have been
developed to identify the respiratory pathogens so as to control the infections timely. The growing number
of infections are demanding more reliable and effective measures to curb respiratory infections. Early
detection of respiratory diseases will minimize the damage caused due to secondary spread of infections.
To detect the respiratory infections, tests are performed at hospitals or diagnostic centers to evaluate the
disease. Respiratory panel assays are carried out to analyze possible infections in the respiratory tract.
Respiratory panel tests are conducted to detect disease and infections immediately to prevent further
damage which in turn will prevent unnecessary antibiotics and reduce the unneeded cost of examination.
Respiratory panel assays detect various respiratory pathogens with increased sensitivity and minimum
sample handling.
To Understand How Our Report Information Can Bring Difference, Ask for a brochure
@ https://www.persistencemarketresearch.com/samples/22888
Technology that has Enhanced the Productivity of Diagnostic Centers
Respiratory panel assay is a new form of technology based on multiplex PCR and molecular testing, which
automatically monitors the results for the tests. Earlier, it was difficult for the physicians to diagnose the
respiratory disease. However, with the advancement of the technology a new technique has been developed
for diagnosis of bacterial and viral respiratory infections. The molecular technique is found to be better than
the conventional PCR technique as it allows small quantities of nucleic acid to be amplified into distinguished
levels. Before the introduction of respiratory panel assay the diagnoses of the infections had become a task
of the physicians which in return caused resistance among various pathogens in individuals. The respiratory
panel assay provides universal tool that is fit to diagnose various bacterial and viral respiratory infections.
Implementation of respiratory panel assay has provided a fully functional environment to physicians that
delivers excellent care, and identifies the disease in a short span of time and simultaneously reduces the
cost of care and provides maximum productivity.
Respiratory Panel Assays Market Assessment by End User

2. Market Segmentation
Based on end users of respiratory panel assay market, the global market has been segmented into hospitals
and diagnostic laboratories. Among the end users diagnostic centers as end-user segment is expected to
hold the highest market share in the global market for the respiratory panel assay.
Factors Driving the Respiratory Panel Assays Market
The global market for respiratory panel assays is driven by increasing rate of toxicities and pollutants the
air. These pollutants get transferred from person to person via air. According to the Center for Disease
Control and Prevention (CDC) there were 25,676 laboratory-confirmed influenza cases which were treated in
hospitals between October 1, 2017 and March 10, 2018. Respiratory panel assay is an easy, fast and
comprehensive technique that helps in identification and diagnoses of the infection. Also, it reduces the cost
of hospital and administration of unnecessary antibiotics. With the early detection of disease the patient can
start with the targeted therapy required for the disease.
Looking for Exclusive Market Insights from Business Experts? Request a Custom Report here
@ https://www.persistencemarketresearch.com/request-customization/22888
Regional Market Outlook
North America will continue to dominate the global market due to the availability of advanced technologies
and more number of laboratory developed tests. Europe is expected to hold second large share in the global
respiratory panel assays market due to growing prevalence of respiratory chronic diseases.
Competition Outlook
Examples of some of the players identified in the global organ function assays market are Accu Reference
Medical Labs, Clarity Lab Solutions, LLC Majority of respiratory panel assays are available in diagnostic
laboratories. However, the point-of-care organ function testing offers a global opportunity to its
manufacturers, it is the common test performed globally.
Small-Scale
Manufacturers/Providers
Medium-Scale
Manufacturers/Providers
Large-Scale
Manufacturers/Providers
 Accu Reference Medical
Labs
 BioMerieux SA
 Clarity Lab Solutions, LLC
 Luminex cooperation
 Hologic
 GenMark Diagnostics Inc.
 Randox Laboratories Ltd
 Thermo Fisher Scientific
Inc.
 Seegene Inc.
Report Highlights:
 Shifting industry dynamics
 In-depth market segmentation
 Historical, current and projected industry size, recent industry trends
 Key competition landscape, market structure, regulatory scenario
 Epidemiology outlook for diseases
 Economical spending, regional healthcare outlook, consumer healthcare expenditure
 Availability of testing, cost of test, specificity and sensitivity of test kits
 Strategies for key players and product offerings, channel strategies, regional foot print, channel
footprint

3.  Potential and niche segments/regions exhibiting promising growth
 A neutral perspective towards market performance in terms of value and volume
To Gain More Insights & Stay Ahead Of The Competition, Buy Now
@ https://www.persistencemarketresearch.com/checkout/22888
Market Segmentation
By Application
 Upper tract infections
 Upper and lower tract infections
By End user
 Hospitals
 Diagnostics Laboratories
By Region
 North America
 Latin America
 Europe
 Asia Pacific Excluding Japan
 Japan
 Middle East & Africa